Stock market on Friday

The US stock market concluded trading on Friday in the green zone amid ubiquitous growth in technology and healthcare stocks, which pushed the S&P 500 and Nasdaq Composite indices to new closing records.

Standard Poor's 500 rose 8.70 points (0.24%) to 3,638.35 points, setting its 26th closing record this year. Nasdaq Composite added 111.44 points (0.92%) to 12205.85 points, reaching its historic high of closing. Dow Jones and S&P 500 added 2.2% and 2.3% respectively over the week, while Nasdaq Composite gained almost 3%.

The Dow Jones Industrial Average Index rose 37.90 points (0.13%) to 29910.37 points, the third highest historical close. The index value at a certain point in the trades once again surpassed the 30000 points mark.

There was no trading on the US exchanges on Thursday due to Thanksgiving.

Among the growth leaders on Friday were retailer stocks, which rose on expectations of good sales on Black Friday in the US.

The price of securities of Etsy Inc., a website for trade between individuals that focuses on handmade and antique items, unique limited edition products, jumped by 10.7%, while securities of the American video game chain GameStop Corp added 9%. The shares of Amazon and Shopify Inc. rose by 0.3% and 1.5%.

Quotations of Tiffany Co securities rose by 0.1%. The American jewellery retail chain will hold an extraordinary meeting of its shareholders in absentia on 30 December 2020.

The capitalisation of Tesla Inc. has increased by 2.1%. On Friday, the State Administration of Market Regulation (SAMR) of the People's Republic of China (PRC) announced that the company is recalling 870 Model X vehicles manufactured in China between 16 March and 31 July 2016 due to the threat of tearing off the outer roof section located between the lifting rear doors.

Previously, it became known that a potential coronavirus vaccine developed by US company Pfizer Inc. and German BioNTech demonstrated 95% effectiveness during the trials. For its part, Moderna Inc. announced that the coronavirus vaccine it was developing had an efficiency of 94.5%.